Body weight is a quantitative trait with significant heritability in humans. To identify potential genetic contributors to this phenotype, we resequenced the coding exons and splice junctions of 58 genes in 379 obese and 378 lean individuals. Our 96-Mb survey included 21 genes associated with monogenic forms of obesity in humans or mice, as well as 37 genes that function in body weight-related pathways. We found that the monogenic obesity-associated gene group was enriched for rare nonsynonymous variants unique to the obese population compared with the lean population. In addition, computational analysis predicted a greater fraction of deleterious variants within the obese cohort. Together, these data suggest that multiple rare alleles contribute to obesity in the population and provide a medical sequencing-based approach to detect them. Obesity is reaching epidemic proportions in developed countries and represents a significant risk factor for hypertension, heart disease, diabetes, and dyslipidemia.
Obesity is reaching epidemic proportions in developed countries and represents a significant risk factor for hypertension, heart disease, diabetes, and dyslipidemia.
1 Although the growing prevalence of obesity in the population is thought to be caused by increasing caloric intake and declining energy expenditure, 2 individual susceptibility to obesity is strongly influenced by heredity. Twin, adoption, and family studies have indicated that 40%-70% of interindividual variation in BMI is heritable.
3,4 In a limited number of cases, single gene defects have been linked to obesity, 5 but the majority of cases are thought to be attributable to complex genetic and/or environmental interactions. In this study, we sought to explore the relationship between sequence variation in multiple candidate genes and the extremes of human body mass.
Candidate genes for the study included (a) 21 genes strongly associated with obesity that, when disrupted, lead to monogenic forms of obesity in humans and/or that cause obesity when inactivated in mice and (b) 37 genes involved in regulation of food intake, 6 adipogenesis, 7 energy expenditure, 8 or lipid metabolism (table 1) . The coding exons and splice junctions of each gene were sequenced in 379 extremely obese (mean BMI 49.0, 195th percentile adjusted for age and sex; BMI was calculated as weight in kilograms divided by square of height in meters) white men and women ascertained through an obesity clinic at the University of Ottawa and in 378 lean (mean BMI 19.4, !10th percentile adjusted for age and sex) apparently healthy white men and women who participated in a study of leanness at the same institution (table 2). A total of 134 kb (60 kb coding and 74 kb noncoding) was sequenced in each individual, representing 96 Mb of highquality sequence data, with an average coverage of 734 individuals per exon (table 3) . Cumulatively, we identified 1,074 genetic variants (see the tab-delimited ASCII file, which can be imported into a spreadsheet, of data set 1 [online only]), averaging one variant per 125 bp of the reference human genome sequence. Of the variants, 252 were common polymorphisms (minor-allele frequency The excess of nonsynonymous variants among obese individuals may reflect chance fluctuation in allele frequencies, population stratification, or the accumulation in this group of functional sequence variants that predispose individuals to obesity. Chance fluctuation in allele frequencies seems unlikely, since the excess of nonsynonymous variants in the obese group was not because of an increased number of variants in any single gene, but rather was because of the aggregate contribution of variants at several unlinked loci. Population stratification also seems improbable, since both groups comprised white men and women from the same region (Ottawa, Canada). Furthermore, the number of synonymous variants (table 1) and the allele frequencies of ∼250 common sequence variants (see below) in these genes were similar in the obese and lean groups. Therefore, it seems likely that the excess of rare variants in the obese group represents the accumulation of functional alleles that contribute to the phenotype in these individuals.
As a first step to assess the functional significance of the nonsynonymous sequence variants identified in the 21 genes associated with monogenic forms of obesity, we used the computer algorithm PolyPhen 174 to predict the effects of amino acid substitutions on protein function. We observed that variants identified in the monogenic obesity gene group were more likely to be deleterious in the obese cohort than in the lean cohort (19 in the obese vs. 4 in the lean;
, by exact binomial test) ( fig. 2A ). P ! .002 In comparison, the number of benign variants (25 in the obese and 21 in the lean) and the number of synonymous variants (18 in the obese vs. 16 in lean) in these genes were similar in both cohorts. In contrast, the distribution of synonymous, benign, and deleterious alleles in the 37 candidate genes not associated with monogenic forms of obesity was similar in the obese and lean groups ( fig. 2B ). This finding is consistent with the notion that the excess of nonsynonymous sequence variants among the monogenic obesity genes in the obese cohort reflects the accumulation of functional variants.
To determine whether nucleotide changes within these genes segregate with BMI, we examined familial segregation for 28 rare variants identified in 14 genes (10 monogenic and 4 candidate genes; see data set 1 [online only]) in obese kindreds, comprising the proband and all firstdegree family members who were available and willing to participate. We used MC4R as a test case, since it is the most common cause of monogenic obesity, estimated to account for 1%-6% of cases of severe obesity. 44 In our study, we identified eight nonsynonymous variants that were unique to the obese cohort, compared with two unique variants in the lean cohort (table 1). We found that the mutant MC4R alleles clearly failed to segregate with obesity in three of the six kindreds with six or more family members available ( fig. 3 ), including an allele with a previously characterized frameshift mutation (L211; 4-bp deletion; fig. 3E ) 175 that is almost certainly functional. To corroborate that these MC4R variants were indeed functional, we performed established in vitro functional assays for the novel MC4R variants 44 identified in our obese population. Of the six putative mutations analyzed for segregation, five displayed impaired MC4R function (table 4) . These findings are consistent with previous studies that also show incomplete correlation between MC4R mutations and obesity, 176, 177 illustrating the difficulties inherent in determining the correspondence between genotype and phenotype in common complex phenotypes such as obesity. Although several of the kindreds available for study were small, none of the other rare variants examined in 13 additional genes showed significant segregation with BMI in a total of 21 kindreds (data not shown), with the exception of PYY (MIM 600781) Q62P, which we have reported elsewhere. 79 Although the goal of our study was not to perform an exhaustive genetic association study between common variants and BMI, we identified 252 polymorphisms with a frequency 11% and examined the frequency distributions of the variants in the obese and lean cohorts (see data set 1 [online only]). We found two variants that displayed a significant frequency difference between the two populations: rs6599571 in DGAT1 (MIM 604900) and rs1800832 in NTS (MIM 162650) (both variants are in the 5 UTR of their gene) (see data set 1 [online only]). In an attempt to replicate these findings, we compared their frequencies in a second obese cohort ( ; mean BMI n p 382 38.6) and a second lean cohort ( ; mean BMI 20.8). n p 381 For both variants, we observed no significant difference in the allele frequencies between the second cohorts (data not shown), supporting the hypothesis that the initial observation was likely a false-positive discovery or limited to very extreme BMI phenotypes. We should further note that none of the 37 sequenced common variants that were examined elsewhere for their association with BMI displayed a significant frequency difference between our original obese and lean groups (table A1 [online only]). These results suggest that, in this population, common variants within the coding regions and their proximal exon-intron junctions in this subset of 58 genes are unlikely to contribute appreciably to susceptibility to extreme BMI. However, because we screened primarily the coding sequences and splice junctions of these genes, we cannot exclude the possibility that common sequence variations in noncoding regions that were not sequenced in this study may have significant effects on BMI.
Whereas the heritability of BMI has been firmly established, the identification of genes that contribute to obesity has proved challenging. Genomewide association scans are becoming more feasible, both technologically and economically, and, with them, investigators have begun to systematically explore common variants that influence obesity. 178 However, such studies fail to capture rare variants that have also been shown to influence human phenotypes. 172, 173 Resequencing of candidate genes selected for biological plausibility, in an attempt to capture such rare variants, has, in a few instances, resulted in the identification of obesity-associated variants. For instance, the observation that Mc4r-knockout mice are obese 43 led to the subsequent finding that mutations in this gene may lead to obesity in humans. 175, 179 In the present study, we sought to use a similar approach, using a large-scale sequencing strategy with numerous obesity candidate genes in two cohorts with extreme BMI. We did not uncover a large number of novel genes associated with obesity, an endeavor that may have been obstructed by reasons that range from a partial candidate-gene list (58 genes), a large but still limited collection of only white individuals ( in each group), the sequencing of mainly codn p∼ 380 ing regions, and limited power and availability of subject pedigrees. However, we did identify several genes that warrant further investigation. For instance, we observed a noteworthy rare nonsynonymous variant difference between the obese and lean cohorts for SIM1 (6 variants in obese vs. 0 in lean) and PRKAG3 (10 in obese vs. 4 in lean), suggesting that nonsynonymous variants within these genes may influence susceptibility to obesity. SIM1 is of particular interest because of its strong biological plausibility, including evidence that human chromosomal aberrations within the SIM1 region may lead to obesity, 83, 84 the observation that Sim1 heterozygous null mice develop obesity, 81 and the absence of reported human obesityassociated rare nonsyndromic variants. In addition, we uncovered a significant difference in the total number of nonsynonymous variants in previously characterized monogenic obesity genes between the obese and lean cohorts, indicating that multiple rare variants may have an incomplete effect on this phenotype. Our familial segregation analysis demonstrated that even thoroughly characterized human monogenic obesity genes, such as MC4R, fail to show consistent linkage with BMI, which further suggests that these variants exhibit variable penetrance. Although our analysis encompassed a modest fraction of candidate BMI genes, it strengthens the hypothesis that the majority of genetic etiology that governs obesity is complex and is likely to be influenced by a combination of multiple susceptibility alleles, the majority of which are not independently causative of extreme BMI.
Subjects.-Unrelated obese white subjects were recruited from the patient population of the University of Ottawa Weight Management Clinic and the Heart Institute Lipid Clinic by use of criteria reported elsewhere. 79 Briefly, inclusion criteria included a BMI 136; a history of obesity for at least 10 years of adult life; no history of treatment with oral glucocorticoids, antipsychotics, or lithium; and no history of medical conditions including major depression, bipolar affective disorder, or psychosis. Unrelated lean subjects of the same ethnic background, with a BMI р10th percentile for age and sex and with no prior history of a BMI 125th percentile for 12 consecutive years were recruited from the Ottawa community (table 2) . Subjects were excluded if they had any medical condition that affects weight gain, such as hypo-or hyperthyroidism, eating disorders, major depression, or malabsorption syndromes. The management of phenotypic data was performed using the SAS statistical package (version 9.1 [SAS Institute]). BMI for obese and lean subjects was categorized according to population percentiles for age and sex by use of the Canadian Heart Health Survey data for subjects aged Sequencing and data analysis.-Primers were designed to give a maximum product size of 500 bp and a minimum of 40 bp flanking the splice sites, by use of the Exon Locator and eXtractor for Resequencing program (ELXR Web site). An M13F tag (gttttcccagtcacgacgttgta) and an M13R tag (aggaaacagctatgaccat) were added to forward and reverse primers, respectively. From each sample, 10 ng of DNA was amplified in a 10-ml PCR by use of AmpliTaq Gold (Applied Biosystems) and was cleaned using the PCR product presequencing kit (USB Corporation). Bidirectional sequencing was performed using both of the M13 primers and BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) (JGI Web site), and cleaning was done with tetraethylene glycol before separation on a 3730xl DNA Analyzer (Applied Biosystems). Base calling, quality assessment, and assembly were performed using the Phred, Phrap, Consed (Green Group Web site), and PolyPhred (PolyPhred Web site) software suite. To filter out low-quality sequence, only sequences that had a Phred score у27 were included in the analysis. To minimize false-negative results, we manually analyzed sequence data after PolyPhred analysis at a rank of 5. In addition, every low-quality read was visually examined for indels. All sequence variants identified were verified by manual inspection of the chromatograms, and 156 (99%) of the 157 nonsynonymous variants were verified by a second independent sequencing reaction. All variants were examined by Arlequin (Arlequin Web site), to test for HardyWeinberg equilibrium (table A1 [ 1,074 genetic variants identified, 12 (4 coding and 8 noncoding) had 150% of the data missing in either the lean or the obese panel and thus were removed from further analysis. PolyPhen analysis.-All coding SNPs were subdivided into groups of frameshift/nonsense variants, synonymous variants, and missense variants. Missense variants were further classified with respect to their potential impact on protein structure or function, on the basis of sequence conservation analyzed using a new version of the PolyPhen method. 174 PolyPhen relies on the analysis of multiple sequence alignments of homologous proteins, together with functional annotation and structural information if available. The new version of PolyPhen constructs multiple sequence alignments by using a pipeline of several existing programs for alignment of sequences, alignment quality control, and clustering of sequences. Computational prediction methods are statistical in nature; therefore, certain percentages of false-positive (∼10%) and false-negative (20%-30%) predictions are expected. However, application of computational predictions increases power to detect differences in the number of rare functional nonsynonymous variants in candidate genes between populations with different phenotypes.
online only]). Of the
MC4R functional analysis.-Cloning and functional studies of the MC4R mutations were performed as described elsewhere. 176, 182, 183 Briefly, since MC4R is a singleexon gene, mutated alleles were amplified and cloned directly from the genomic DNA of the patient. This also allowed for confirmation of the presence and the nature of the mutations. Human MC4R alleles were cloned into the pcDNA3 expression vector (Invitrogen), to express the native form and the N-terminal FLAG-tagged and/or Cterminal V5His-tagged form of the receptor. All expression vectors were sequenced, to establish the presence of the mutation and the absence of PCR-induced mutations.
For alpha-melanocyte stimulating hormone (alpha-MSH) activation studies, receptors were transiently transfected into an human embryonic kidney (HEK) 293 cell line stably expressing luciferase under the control of a cAMP-responsive promoter. 182 Cells were split into 96-well plates 24 h after transfection, and, 36 h after transfection, they were washed and incubated in stimulation medium (Minimum Essential Medium-alpha containing 0.1 mg/ ml BSA and 0.25 mM isobutylmethylxanthine) and were stimulated with different concentrations of alpha-MSH (Sigma) for 6 h at 37ЊC in a 5% CO 2 incubator. Luciferase activity, representing cAMP produced in response to alpha-MSH, was assessed using the Steady-Glo Luciferase Assay System (Promega) and a microplate luminescence counter (Packard Instrument). Results were normalized to the maximal stimulation by 8Br-cAMP. Basal activity of the receptors was determined by transient cotransfection with the cAMP-dependent luciferase-expressing plasmid. All experiments were normalized for transfection efficiency by cotransfection of a plasmid encoding the Renilla luciferase-expression plasmid pRL-RSV, to control for transfection efficiency. Data were analyzed using the GraphPad Prism software (GraphPad Software).
Statistical analysis of common variants.-Common SNPs were preprocessed to remove triallelic SNPs (one SNP removed) and SNPs for which 150% of the data were missing (three SNPs removed). In addition, we clustered together SNPs that differed in at most three individuals, picking one representative from each such cluster. Standard x 2 tests based on a contingency were applied for each 3 # 2 of the remaining 252 SNPs, on the basis of a contingency table of genotype-phenotype frequencies. The obtained P values were adjusted for multiple SNP testing by use of the false-discovery-rate procedure. 
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